We don’t support this browser anymore.
This means our website may not look and work as you would expect. Read more about browsers and how to update them here.

Beyond Air Inc (XAIR) USD0.0001

Sell:$1.08 Buy:$1.14 Change: $0.01 (0.91%)
Market closed |  Prices as at close on 24 May 2024 | Switch to live prices |
Sell:$1.08
Buy:$1.14
Change: $0.01 (0.91%)
Market closed |  Prices as at close on 24 May 2024 | Switch to live prices |
Sell:$1.08
Buy:$1.14
Change: $0.01 (0.91%)
Market closed |  Prices as at close on 24 May 2024 | Switch to live prices |
The selling price currently displayed is higher than the buying price. This can occur temporarily for a variety of reasons; shortly before the market opens, after the market closes or because of extraordinary price volatility during the trading day.

Business summary

Beyond Air, Inc. is a commercial-stage medical device and biopharmaceutical company developing a platform of nitric oxide (NO) generators and delivery systems (the LungFit platform) capable of generating NO from ambient air. The Company’s LungFit platform can be used to treat patients on ventilators that require NO, as well as patients with chronic or acute severe lung infections through delivery through a breathing mask or similar apparatus. The Company’s areas of focus with LungFit are persistent pulmonary hypertension of the newborn (PPHN), viral community-acquired pneumonia (VCAP), including COVID-19, bronchiolitis (BRO), nontuberculous mycobacteria (NTM) lung infection and various severe lung infections with underlying chronic obstructive pulmonary disease (COPD). Its LungFit PH is an ionizer technology that generates on-demand NO from ambient air and, regardless of dose or flow, delivers it to a ventilator circuit. The LungFit can generate up to 400 parts per million (ppm) of NO.

Contact details

Address:
900 STEWART AVENUE, SUITE 301
GARDEN CITY
11530
United States
Telephone:
+1 (516) 6658200
Website:
https://www.beyondair.net/

Important dates

Future events
There are no future events available.
Past events
There are no past events available.

General stock information

Short code:
XAIR
ISIN:
US08862L1035
Market cap:
$55.54 million
Shares in issue:
45.90 million
Sector:
Health Care Equipment
Exchange:
NASDAQ
Country:
United States
Currency:
US dollar
Indices:
n/a

Key personnel

  • Steven Lisi
    Chairman of the Board, Chief Executive Officer
  • Amir Avniel
    President, Director, Chief Business Officer
  • Douglas Larson
    Chief Financial Officer
  • Michael Gaul
    Chief Operating Officer
  • Jeff Myers
    Chief Medical Officer

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Business summary, contact details and key personnel provided by Thomson Reuters. Important dates provided by Digital Look Ltd. General stock information provided by Reuters.

Share

The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.

Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.